Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Mazzucchelli

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Oncotarget|September 24, 2017
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerChiara Avellini, Caterina Licini, Raffaella Lazzarini, et al.
Urologic Oncology|July 30, 2014
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinomaDaniele Minardi, Matteo Santoni, Guendalina Lucarini, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstructionRodolfo Montironi, Liang Cheng, Roberta Mazzucchelli, et al.
Anticancer Research|January 1, 2015
Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expressionDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Current Drug Targets|October 19, 2019
Combining Radiotherapy with Immunocheckpoint Inhibitors or CAR-T in Renal Cell CarcinomaMatteo Santoni, Daniel Y C Heng, Gaetano Aurilio, et al.
International Journal of Cancer|May 29, 2013
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarkerTeresa Lorenzi, Maria Lorenzi, Emma Altobelli, et al.
Metabolism: Clinical and Experimental|November 19, 2009
Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humansMarica Bordicchia, Ilaria Battistoni, Lucia Mancinelli, et al.
Case Reports in Nephrology and Dialysis|June 24, 2025
Plasma Glycolate Levels Contribute to Drive the Decision of Isolated Kidney Transplantation in Dialyzed Patients with End-Stage Kidney Disease due to Primary Hyperoxaluria Type 1 Treated with Lumasiran: A Case ReportMaria Ilaria Moretti, Marta Leporati, Roberta Mazzucchelli, et al.
Anticancer Research|October 3, 2018
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell CarcinomaMatteo Santoni, Francesco Piva, Ugo De Giorgi, et al.
The Prostate|May 4, 2011
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomyTineke Wolters, Rodolfo Montironi, Roberta Mazzucchelli, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Oncotarget|September 24, 2017
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerChiara Avellini, Caterina Licini, Raffaella Lazzarini, et al.
Urologic Oncology|July 30, 2014
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinomaDaniele Minardi, Matteo Santoni, Guendalina Lucarini, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstructionRodolfo Montironi, Liang Cheng, Roberta Mazzucchelli, et al.
Anticancer Research|January 1, 2015
Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expressionDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Current Drug Targets|October 19, 2019
Combining Radiotherapy with Immunocheckpoint Inhibitors or CAR-T in Renal Cell CarcinomaMatteo Santoni, Daniel Y C Heng, Gaetano Aurilio, et al.
International Journal of Cancer|May 29, 2013
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarkerTeresa Lorenzi, Maria Lorenzi, Emma Altobelli, et al.
Metabolism: Clinical and Experimental|November 19, 2009
Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humansMarica Bordicchia, Ilaria Battistoni, Lucia Mancinelli, et al.
Case Reports in Nephrology and Dialysis|June 24, 2025
Plasma Glycolate Levels Contribute to Drive the Decision of Isolated Kidney Transplantation in Dialyzed Patients with End-Stage Kidney Disease due to Primary Hyperoxaluria Type 1 Treated with Lumasiran: A Case ReportMaria Ilaria Moretti, Marta Leporati, Roberta Mazzucchelli, et al.
Anticancer Research|October 3, 2018
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell CarcinomaMatteo Santoni, Francesco Piva, Ugo De Giorgi, et al.
The Prostate|May 4, 2011
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomyTineke Wolters, Rodolfo Montironi, Roberta Mazzucchelli, et al.
Pageof 18